Patent Assignment
Reel/Frame 059051/0340
Assignment of Assignor's Interest
Recorded: 2022-02-18
Pages: 5
Assignor
TARSA THERAPEUTICS, INC.
Executed: 2018-11-20
Assignee
TAURUS DEVELOPMENT COMPANY LLC
505 COAST BLVD. SO., SUITE 102, LA JOLLA, CALIFORNIA, 92037
Covered Property
(1)
Room Temperature Stable Oral Calcitonin Formulation
Related Assignments
(4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Feb 18, 2022
From: DAGGS, THOMAS A.; SHIELDS, PAUL P.
To: ENTERIS BIOPHARMA, INC.
Reel/Frame 059051/0284 →
Assignment of Assignor's Interest
Feb 18, 2022
From: GILLIGAN, JAMES P.; MAURER, GEORGE R.; RAILKAR, ANIRUDDHA M.; BAUER, PHIL
To: TARSA THERAPEUTICS, INC.
Reel/Frame 059051/0297 →
Assignment of Assignor's Interest
Jan 5, 2023
From: TAURUS DEVELOPMENT COMPANY LLC
To: PARK THERAPEUTICS, INC.
Reel/Frame 062287/0841 →
Corrective Assignment to Correct the the Assignment Previously Recorded Previously Recorded at Reel: 068713 Frame: 0499. Assignor(S) Hereby Confirms the Assignment.
Oct 24, 2024
From: TRIS PHARMA, INC.; PARK THERAPEUTICS, INC.
To: PROVIDENT BANK
Reel/Frame 070760/0864 →